David B. Ring
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Immunology top 10%
- Toxin Mechanisms and Immunotoxins
- Immunotherapy and Immune Responses
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 18
-
- Toxin Mechanisms and Immunotoxins 4
- Immunotherapy and Immune Responses 4
- Co-authors
- Arthur E. Frankel (7 shared papers)Stephen D. Harrison (2 shared papers)Kirk W. Johnson (2 shared papers)Tyson R. Kinnick (2 shared papers)Erik John Henriksen (2 shared papers)Louis M. Weiner (6 shared papers)R. Katherine Alpaugh (6 shared papers)Michael J. Bjorn (4 shared papers)
- Journals
- Cancer Immunology Immunotherapy (3 papers)Molecular Immunology (2 papers)American Journal of Clinical Pathology (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)Human Gene Therapy (1 paper)
- Partner nations
- United StatesSwitzerlandAustralia
In The Last Decade
David B. Ring
33 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 69
- Radiology, Nuclear Medicine and Imaging 328
- Immunology 247
- Oncology 184
- Molecular Biology 376
- Virology 25
Countries citing papers authored by David B. Ring
This map shows the geographic impact of David B. Ring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Ring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Ring more than expected).
Fields of papers citing papers by David B. Ring
This network shows the impact of papers produced by David B. Ring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Ring. The network helps show where David B. Ring may publish in the future.
Co-authors
The 25 scholars most cited alongside David B. Ring, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 434 | |
| 2 | Phase I trial of 2B1, a bispecific monoclonal antibody targeting c-erbB-2 and Fc gamma RIII. | 1995 | 117 |
| 3 | Evaluation of monoclonal antibodies for the development of breast cancer immunotoxins. | 1985 | 103 |
| 4 | 2003 | 92 | |
| 5 | Tissue distribution of breast cancer-associated antigens defined by monoclonal antibodies. | 1985 | 82 |
| 6 | 1995 | 47 | |
| 7 | 1993 | 42 | |
| 8 | Differential induction by interferons of major histocompatibility complex-encoded and non-major histocompatibility complex-encoded antigens in human breast and ovarian carcinoma cell lines. | 1989 | 35 |
| 9 | 1999 | 34 | |
| 10 | 2017 | 34 | |
| 11 | Elevated levels of a high molecular weight antigen detected by antibody W1 in sera from breast cancer patients. | 1986 | 33 |
| 12 | 1990 | 29 | |
| 13 | 1991 | 27 | |
| 14 | 1989 | 24 | |
| 15 | 1991 | 24 | |
| 16 | In vitro cytotoxic targeting by human mononuclear cells and bispecific antibody 2B1, recognizing c-erbB-2 protooncogene product and Fc gamma receptor III. | 1992 | 24 |
| 17 | Distribution and physical properties of BCA200, a Mr 200,000 glycoprotein selectively associated with human breast cancer. | 1989 | 22 |
| 18 | 1995 | 21 | |
| 19 | 1988 | 20 | |
| 20 | Use of immunotoxins in combination to inhibit clonogenic growth of human breast carcinoma cells. | 1990 | 20 |
About David B. Ring
David B. Ring is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Oncology, Cancer Research and Molecular Biology, having authored 33 papers that have together received 1.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (18 papers), Toxin Mechanisms and Immunotoxins (4 papers), Immunotherapy and Immune Responses (4 papers), HER2/EGFR in Cancer Research (4 papers), Glycosylation and Glycoproteins Research (3 papers), Metabolism, Diabetes, and Cancer (2 papers), Natural Antidiabetic Agents Studies (2 papers) and Synthesis and biological activity (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (328 citations), Immunology (247 citations), Oncology (184 citations), Molecular Biology (376 citations) and Virology (25 citations). David B. Ring has collaborated with scholars based in United States, Switzerland and Australia. Frequent co-authors include Arthur E. Frankel, Stephen D. Harrison, Kirk W. Johnson, Tyson R. Kinnick, Erik John Henriksen, Louis M. Weiner, R. Katherine Alpaugh, Michael J. Bjorn, John M. Nuss and Allan S. Wagman. Their work appears in journals such as Cancer Immunology Immunotherapy, Molecular Immunology, American Journal of Clinical Pathology, Bioorganic & Medicinal Chemistry Letters and Human Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.